Salona Global Appoints Michael Seckler, Medical Sales & Marketing Senior Executive, as Interim CEO; Adjusts Management Team with a Focus on Cash Flow
14 6월 2023 - 8:30PM
Salona Global Medical Device Corporation (“
SGMD”,
“
Salona Global” or the “
Company”)
(TSXV:SGMD) is pleased to announce the appointment of Michael
Seckler as interim CEO, effective June 13, 2023. Mr. Seckler has a
long and successful track record as a senior executive of Ferring
Pharmaceuticals, a multi-billion dollar company based in
Switzerland, where he was the General Manager of its Canadian
subsidiary before being promoted to Vice President of Global
Marketing and Corporate Communications. He was most recently a
senior executive of FerGene, a Ferring subsidiary focused on gene
therapy.
With the addition of Lana Newishy as Vice Chair
of the Board, the Company has completed its goal of adjusting the
management team with a focus on cash flow and debt service as a
priority. Mr. Faulstick remains a non-executive director of the
Board.
“We continue to add to our board and team as we
integrate the Biodex asset and look beyond to our next stage of
growth,” said Les Cross, Non-Executive Chairman. “I want to
personally thank Luke for his management tenure at Salona. He took
a small business in SDP and helped lead the Company through a
crucial period of important acquisitions and revenue growth.
Clearly our first priority now is generating cash flow from
operations and restructuring our debt. With the addition of Mike
Seckler, we can also focus on increasing revenues. Mike has a
strong background in global medical sales and marketing on a larger
scale and I am looking forward to his help in focusing on our five
engines of growth and getting back to the momentum we had in
2022.”
In connection with his appointment as interim
CEO, Mr. Seckler has been granted options under the Company’s
Stock Option Plan to purchase up to 250,000 common shares, vesting
equally over a three year period, with a term of five years and an
exercise price of $0.25. The options and underlying common shares
are subject to a four month and one day hold period pursuant to
the TSX Venture Exchange.
In connection with overhead cost reduction
measures, Joseph Martinez (former Senior Vice President, Legal
& Compliance, General Counsel and Secretary) is no longer
working full time for the Company, but continues to be available on
an hourly consulting basis.
For more information please contact:
Mike SecklerInterim Chief Executive OfficerTel:
1 (800) 760-6826 Email: Info@Salonaglobal.com
Additional Information
Neither the TSXV nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
Certain statements contained in this press
release constitute "forward-looking information" within the meaning
of the Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities laws. These statements can be
identified by the use of forward-looking terminology such as
“expects”, “believes”, “estimates”, "may", "would",
"could", "should", "potential", "will", "seek",
"intend", "plan", and "anticipate", and similar expressions as they
relate to the Company.
All statements other than statements of
historical fact may be forward-looking information. Such statements
reflect the Company's current views and intentions with respect to
future events, and current information available to the
Company, and are subject to certain risks, uncertainties and
assumptions. Salona cautions that the forward-looking statements
contained herein are qualified by important factors that could
cause actual results to differ materially from those reflected by
such statements. Such factors include but are not limited to
the general business and economic conditions in
the regions in which Salona operates; the ability of Salona to
execute on key priorities, including the successful
completion of acquisitions, business retention,
and strategic plans, and to attract,
develop and retain key executives; difficulty
integrating newly acquired businesses; ongoing or new
disruptions in the supply chain, the extent and scope of such
supply chain disruptions, and the timing or extent of the
resolution or improvement of such disruptions; the ability to
implement business strategies and pursue business opportunities;
disruptions in or attacks (including cyber-attacks) on
Salona’s information technology, internet, network access or
other voice or data communications systems or
services; the evolution of various types of fraud or
other criminal behavior to which Salona is
exposed; the failure of third parties to comply with their
obligations to Salona or its affiliates; the impact of
new and changes to, or application of, current laws and
regulations; granting of permits and licenses in a highly
regulated business; the overall
difficult litigation environment, including in the United
States; increased competition; changes in foreign currency
rates; increased funding costs and market volatility
due to market illiquidity and competition for funding; the
availability of funds and resources to pursue operations; critical
accounting estimates and changes to accounting standards,
policies, and methods used by Salona; the occurrence of
natural and unnatural catastrophic events and
claims resulting from such events; www.sec.gov, and
with the securities regulatory authorities in certain provinces of
Canada and available at www.sedar.com. Should any factor
affect Salona in an unexpected manner, or should assumptions
underlying the forward-looking information prove incorrect, the
actual results or events may differ materially from the results
or events predicted. Any such forward-looking information is
expressly qualified in its entirety by this cautionary
statement. Moreover, Salona does not assume responsibility for
the accuracy or completeness of such forward-looking information.
The forward-looking information included in this press release
is made as of the date of this press release and the Company
undertakes no obligation to publicly update or revise any
forward-looking information, other than as required by applicable
law.
Salona Global Medical De... (TSXV:SGMD)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Salona Global Medical De... (TSXV:SGMD)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025